Advertisement

Topics

Navamedic ASA NAVA Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

09:56 EDT 19 Jun 2017 | BioPortfolio Report Blog

Navamedic ASA NAVA Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

Navamedic ASA Navamedic is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. The company's Medtech business unit launched a single use, digital urine meter under the brand name Sippi for patients in intensive care. Navamedic's Pharma and Healthcare business is a distributor of products from a number of drug manufacturers. Navamedic has distribution agreement with Aspen pharma, Sequenom Laboratories and Biotech Pharmacon. The company distributes products to hospitals, physicians, pharmacies and health product stores in the Nordic and Benelux regions. The company has operational presence in Sweden, Finland, Denmark, Norway and Iceland. Navamedic is headquartered in Lysaker, Oslo, Norway.

Navamedic ASA Key Recent Developments

May 10,2017: Navamedic: Q1 2017 Results
Feb 15,2017: Navamedic: Q4 2016 results
Nov 11,2016: Navamedic: Q3 2016 Results
Aug 23,2016: Navamedic appoints new CFO
Aug 18,2016: Navamedic: Q2 2016 RESULTS

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Navamedic ASA NAVA Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Navamedic ASA NAVA Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...